Drug Trial Radar · NCT06430866
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
Last checked: Nov 19, 2026Latest source record: Apr 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
163
Actual
Start
Sep 12, 2024
Primary completion
Dec 14, 2026
Study completion Dec 14, 2026
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- May 28, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to demonstrate pharmacokinetic (PK) similarity ABP 234 with pembrolizumab.
Conditions
- Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
Interventions
ABP 234Drug
Administered by intravenous (IV) injection.
PembrolizumabDrug
Administered by IV injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area Under the Serum Concentration-time Curve (AUC) From Time 0 to 21 Days (AUC21d) Following the First DoseTime frame: 21 days
- AUC at Steady State Between Week 16 and Week 19 (AUCtau_ss)Time frame: Weeks 16-19
Locations
128 sites in 18 countries. Site status is shown where the registry gives one.
Ionc Instituto Oncologico De Cordoba
Córdoba, Argentina
Fundacion ARS Medica
San Salvador de Jujuy, Jujuy Province, Argentina
Instituto de Oncologia de Rosario
Rosario, Santa Fe Province, Argentina
University Multiprofile Hospital for Active Treatment Sofiamed
Sofia, Bulgaria
K2 Oncology
Santiago, Chile
Icegclinic Research and Care
Santiago, Chile
CDIEM - Centro de Investigacion y Especialidades Medicas
Providencia, Region Metropolotana, Chile
Instituto Oncologico Fundacion Arturo Lopez Perez (FALP)
Providencia, Santiago Metropolitan, Chile
Centro de Oncologia de Precision
Region Metropolitana, Santiago Metropolitan, Chile
Clinica Santa Maria
Santiago, Santiago Metropolitan, Chile
Centro de Investigaciones Clinicas Vina del Mar Ltda.
Viña Del Mar, Valparaiso, Chile
Centro de Investigacin de Enfermedades Respiratorias e Inmunologicas Limitada CIERI
Viña del Mar, Valparaiso, Chile
Clinique Belharra Ramsay Sante
Bayonne, France
Centre Hospitalier Universitaire de Bordeaux - Hopital Saint - Andre
Bordeaux, France
Centre Francois Baclesse
Caen, France
Hopital Europeen Marseille
Marseille, France
Hopital Bichat, APHP
Paris, France
Centre Hospitalier Intercommunal Toulon La Seyne Sur Mer (C.H.I.T.S) - Hopital Sainte Musse
Toulon, France
Hopital Robert Schuman
Vantoux, France
LLC Todua Clinic
Tbilisi, Georgia
New Hospitals
Tbilisi, Georgia
Studienzentrum Aschaffenburg
Aschaffenburg, Germany
Kliniken Essen Mitte, Evang. Huyssens-Stiftung, Internistische Onkologie und Hmatologie mit integire
Essen, Germany
Azienda Ospedaliero - Universitaria di Ferrara
Cona, Italy
Azienda Ospedaliera S. Croce e Carle
Cuneo, Italy
Azienda Ospedaliero-Universitaria Careggi
Florence, Italy
Ospedale Versilia
Lucca, Italy
Azienda USL 2 Lucca
Lucca, Italy
AOU Cagliari-Policlinico Universitario Duilio Casula di Monserrato-UOC Oncologia Medica
Monserrato, Italy
ASL Napoli 1 Centro-Ospedale del Mare
Naples, Italy
Casa Di Cura Polispecialistica Dott Pederzoli
Peschiera del Garda, Italy
AUSL Della Romagna - Ospedale S.Maria delle Croci
Ravenna, Italy
IRCCS Istituto clinico humanitas - Humanitas Mirasole spa
Rozzano, Italy
Azienda Ospedaliera Santa Maria Terni
Terni, Italy
ASST Sette Laghi
Varese, Italy
Raja Perempuan Zainab II Hospital
Kota Bharu, Kelantan, Malaysia
Hospital Canselor Tuanku Muhriz UKM
Cheras, Kuala Lumpur, Malaysia
Hospital Umum Sarawak
Kuching, Sarawak, Malaysia
Clinica Integral Internacional de Oncolgia S de RL de CV
Puebla City, Mexico
Preparaciones Oncolgicas S.C.
León, Guanajuato, Mexico
Showing 40 of 128 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.